These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2396396)

  • 1. [Changes in the fractions of atherogenic and antiatherogenic lipoproteins in patients with chronic bronchitis].
    Ionov VA
    Vrach Delo; 1990 May; (5):64-6. PubMed ID: 2396396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atherogenesis in bronchial asthma patients: its relationship to the pathogenetic characteristics of the disease and to liver function (the clinico-biochemical aspects)].
    Mikhaĭlov AM; Andriushchenko OM; Efanov AN
    Ter Arkh; 1993; 65(12):58-61. PubMed ID: 8146774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the immune and fibrinolytic systems in the inhibition of atherogenesis in chronic obstructive bronchitis].
    Kamenev VF; Bratchik AM
    Lik Sprava; 1992 Apr; (4):70-2. PubMed ID: 1441383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-atherogenic effect of enterosorption in patients with diabetes mellitus].
    Bodnar PN; Pristupiuk AM; Romashkan SV; Novopashennaia VV
    Ter Arkh; 1987; 59(11):26-9. PubMed ID: 3441861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differential use of apolipoproteins and lipoproteins as discriminators for atherogenic risk].
    Mertz DP; Göhmann E; Ostertag J
    Med Welt; 1981 Oct; 32(43):1611-5. PubMed ID: 7300661
    [No Abstract]   [Full Text] [Related]  

  • 6. [Molecular analysis of atherogenic and protective lipoproteins].
    Fruchart JC; Bard JM; Fievet C; Puchois P
    Arch Mal Coeur Vaiss; 1987 Sep; 80 Spec No():13-6. PubMed ID: 2445318
    [No Abstract]   [Full Text] [Related]  

  • 7. [The efficacy of piracetam in treating patients with chronic bronchitis and concomitant atherosclerosis].
    Nikitin AV; Chesnokova IV; Sysoeva LI
    Vrach Delo; 1990 Nov; (11):17-8. PubMed ID: 2098971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The vasoactive properties of different classes of blood lipoproteins in hypercholesterolemia and atherosclerosis].
    Frol'kis VV; Kul'chitskiĭ OK; Novikova SN; Sykalo NV; Potapenko RI; Mozzhukhina TG; Bogatskaia LN; Burchinskaia MK
    Patol Fiziol Eksp Ter; 2000; (1):15-7. PubMed ID: 10741181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modified lipoproteins--their types and role in atherogenesis].
    Bratus' VV; Talaieva TV; Lomakovs'kyĭ OM; Tretiak IV; Radalovs'ka NV
    Fiziol Zh (1994); 2000; 46(2):73-81. PubMed ID: 10867865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of a systemic inflammatory process in the atherogenic modification of lipoproteins and the development of hypercholesterolemia].
    Bratus' VV; Talaieva TV; Radalovs'ka NV; Tretiak IV
    Fiziol Zh (1994); 1999; 45(1-2):40-9. PubMed ID: 10202635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperlipoproteinemia. A risk factor in peripheral-arterial and coronary occlusive disease].
    Schwartzkopff W; Thonig S; Sorge F; Hoffmann H; Krüger B; Diehl HJ; Sonderkamp H
    Arzneimittelforschung; 1972 Oct; 22(10):1811-5. PubMed ID: 4678570
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the blood plasma lipid and lipoprotein levels in chronic obstructive bronchitis].
    Shaliapina IV; Malakhova MIa; Aleksandrova NI; Triufanov VF; Lozovskiĭ VT
    Ter Arkh; 1983; 55(3):68-70. PubMed ID: 6857537
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes of tissue factor pathway in essential hypertension].
    Zhang WR; Sun M; Zhou HY; Wu S; He J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):347-8. PubMed ID: 16136978
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on the change of the serum lipids and lipoproteins in patients with arteriosclerosis due to aging].
    Kajiyama G; Mizuno T; Asakura Y; Inoue M; Sumida N
    Naika Hokan; 1972 Mar; 19(3):71-8. PubMed ID: 4339421
    [No Abstract]   [Full Text] [Related]  

  • 15. Atherogenic risk in patients undergoing regular dialysis treatment: improvement of lipid pattern and lipoproteins by polyunsaturated omega-3 fatty acids.
    Dionisio P; Caramello E; Bergia R; Valenti M; Cornella C; Pagni R; Bajardi P
    Nephrol Dial Transplant; 1994; 9(4):458. PubMed ID: 8084465
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relations between carbohydrate loading and arteriosclerosis. II. Behavior of blood cholesterol and serum lipoprotein fractions in normal subjects and patients with cardiovascular diseases after intravenous administration of glucose].
    Smedile G; Squillaci S; Grasso E; Quattrocchi G
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):936-40. PubMed ID: 4463982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum lipoproteins in different types of obesity in lipid loading challenge].
    Sokolov EI; Gorbachëva OI; Shukina GN; Ol'fer'ev AM; Fomina VM; Perova NV; Demidov IuI
    Klin Med (Mosk); 2004; 82(4):25-9. PubMed ID: 15164503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arteriosclerosis indices of lipid and lipoprotein metabolism].
    Reuter W; Herrmann W; Voigt H; Köhler H; Schütz C; Hanf S; Lindhofer HG; Kuklinski B
    Z Arztl Fortbild (Jena); 1984; 78(6):239-41. PubMed ID: 6730538
    [No Abstract]   [Full Text] [Related]  

  • 19. [Change in the properties of model membranes interacting with atherogenic and "antiatherogenic" classes of lipoproteins with varying physicochemical characteristics].
    Gerasimova EN; Perova NV; Pasechnik VI; Ruuge EK; Tverdislov VA
    Kardiologiia; 1980 Aug; 20(8):12-5. PubMed ID: 7412087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in serum cholesterol and prebeta-lipoproteins in patients with ischemic heart disease].
    Voslárová Z; Kucerová L; Papezová R
    Sb Lek; 1973 Aug; 75(8):251-6. PubMed ID: 4731467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.